Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clearmind Medicine Inc. - Common Shares (NQ: CMND ) 1.500 -0.060 (-3.85%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Clearmind Medicine Inc. - Common Shares < Previous 1 2 3 4 5 6 Next > Why Is Penny Stock Clearmind Gaining Today? December 24, 2024 Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder. Via Benzinga Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket October 11, 2024 Via Benzinga Clearmind Medicine Files International Patent For Ibogaine Combination Therapy September 17, 2024 Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes August 23, 2024 Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addressing Alcohol Use Disorder. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday August 09, 2024 We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns! Via InvestorPlace CMND Stock Earnings: Clearmind Medicine Reported Results for Q2 2024 June 17, 2024 Clearmind Medicine just reported results for the second quarter of 2024. Via InvestorPlace Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket August 09, 2024 Via Benzinga Nasdaq Edges Lower; Morgan Stanley Earnings Top Views July 16, 2024 Via Benzinga Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga Crude Oil Down 1%; Bank of America Posts Upbeat Earnings July 16, 2024 Via Benzinga Exposures Fossil Fuels Why Is SciSparc (SPRC) Stock Up 25% Today? July 16, 2024 SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment. Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Dow Jumps 400 Points; US Retail Sales Flat For June July 16, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher June 28, 2024 Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge behavior regulator program through the granting of patent approval in... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Day Trading My Way From Red To Green June 23, 2024 I set daily profit goals and max loss limits to manage my risk. My daily goal is $5,000, and I cap my daily loss at the same amount. Via Talk Markets What's Going On With Clearmind Medicine Stock Tuesday? June 11, 2024 Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the no/low alcohol category is forecasted to grow at a volume CAGR of more... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 07, 2024 Via Benzinga Why Clearmind Medicine Stock Is Moving Higher May 07, 2024 Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Via Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket March 20, 2024 Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. Via Benzinga Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors March 12, 2024 Via Benzinga Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds February 27, 2024 Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents February 21, 2024 SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health. Via Benzinga Topics Intellectual Property Exposures Intellectual Property What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? February 20, 2024 SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Via Benzinga < Previous 1 2 3 4 5 6 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
